Profiling of Circulating Tumor Cells for Screening of Selective Inhibitors of Tumor-Initiating Stem-Like Cells

Investigators identified circulating tumor cell-biomarkers and effective combinations of tumor-initiating stem-like cell-specific, repurposed FDA-approved drugs.
[Advanced Science]
Full Article
spot_img

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News